Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Immunology and molecular biology of Echinococcus infections
1990
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
1998
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 Standout
Apoptosis by Death Factor
1997 Standout
Weight loss and malnutrition in patients with chronic graft-versus-host disease
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study
1994
Clinically Significant Drug Interactions with Cyclosporin
1996
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration
2003
Animal models of autoimmunity and their relevance to human diseases
2000 StandoutNobel
Activity‐based costs of blood transfusions in surgical patients at four hospitals
2009 Standout
Chronic graft-versus-host disease
2003 Standout
Invasive Aspergillosis in Transplant Recipients
1999
Thalidomide for the Treatment of Chronic Graft-versus-Host Disease
1992
The mechanism of action of cyclosporin A and FK506
1992 Standout
Non-infectious complications of transfusion therapy
2001
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation
2010 StandoutNobel
Immunopathology of Echinococcosis
1997
Drug target validation and identification of secondary drug target effects using DNA microarrays
1998 StandoutNobel
Hematopoietic Stem-Cell Transplantation
2006 Standout
Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease
2001
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
1994
Subclinical Thyroid Disease
2004 Standout
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study
1988 StandoutNobel
Bone Marrow Transplantation
1994
Cyclosporine
1989 Standout
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Cyclosporin A — a chemoprotectant against microcystin-LR toxicity
1990
Interactions of Cyclosporine with Antimicrobial Agents
1989
Developmental pharmacodynamics of cyclosporine
1999
The potential use of thalidomide in the therapy of graft-versus-host disease—A review of clinical and laboratory information
1990
Cyanobacteria secondary metabolites—the cyanotoxins
1992 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Pancreatic insufficiency in patients with chronic graft-versus-host disease
2001
The Lysosomotropic Amines, Chloroquine and Hydroxychloroquine: A Potentially Novel Therapy for Graft-Versus-Host Disease
1997
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft‐versus‐host disease: A randomized double‐blind study in patients undergoing allogeneic marrow transplantation
1987
Development of a prognostic model for grading chronic graft-versus-host disease
2001
Intestinal and hepatic complications of human bone marrow transplantation. Part I
1986
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients
1984
Suppression of Thyrotropin in the Low-Thyroxine State of Severe Nonthyroidal Illness
1985
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
1997 Science
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia
1985
Allogeneic Marrow Transplantation
1984
Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor α Antibodies on Acute Graft-Versus-Host Disease Pathologies
1998
Acute and chronic graft-versus-host disease in man
1986
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
1989
Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern
2004 Standout
The pathophysiology and treatment of graft-versus-host disease
1983
Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
1983
Primary Biliary Cirrhosis
2011 Standout
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease
1988
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77.
1995
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation
1996
Peripheral Blood Stem Cell Transplantations: Past, present and future
1993
BONE MARROW TRANSPLANTATION: A REVIEW OF DELAYED COMPLICATIONS
1984 StandoutNobel
The pharmaceutics and delivery of therapeutic polypeptides and proteins
1993
Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial
1990
Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG
1988
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
1997 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Bone Marrow Transplant
1990 Standout
Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide
1997
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.
1996
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Thalidomide for treatment of patients with chronic graft-versus-host disease
2000
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Prevention of Nosocomial Infections in Marrow Transplant Patients: A Prospective Randomized Comparison of Systemic Antibiotics Versus Granulocyte Transfusions
1986 StandoutNobel
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft- versus-host disease
1985
Lymphokine gene expression in vivo is inhibited by cyclosporin A.
1990
Prevention and control of cystic echinococcosis
2007 Standout
Works of AD Hess being referenced
Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat
1989
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]
1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]
1992
Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants
1983
Therapy of chronic graft-v-host disease in a rat model
1989
Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
1987
Graft-versus-host disease: new directions for a persistent problem
1994
Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
1988
Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat
1989
Syngeneic/Autologous Graft-vs-Host Disease: Mobilization of Autoimmune Mechanisms as Antitumor Immunotherapy.
1994
Therapy of chronic graft-v-host disease in a rat model
1989
Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
1988
Graft-versus-host disease: new directions for a persistent problem
1994